Notably, asthmatic patients exhibit reduced IL-10 production compared with healthy individuals, suggesting that therapies aimed at enhancing IL-10 in the lungs may provide a novel approach to controlling allergic asthma (5). This evidence concerns the gene IL10 and allergic asthma.